Full-Time
Patient Care Consultant
Updated on 9/3/2026
Jushi
201-500 employees
Cannabis products brand and wellness solutions
No salary listed
Bristol, PA, USA
In Person
On-site in Bristol, PA. Occasional local travel.
Bachelor's, Associate's
 Retail (1) |
|---|
Get referred to Jushi
See people who can refer or advise you
- High School diploma or General Education Development (GED) required
- Minimum of 2 years’ experience with customer service in retail
- Excellent computer, mathematical, language and reasoning skills
- Excellent multi-tasking skills over the phone and in person
- Occasionally requires local travel, as needed
- Adhere to the company mission statement and core values, while maintaining high ethical standards and professionalism
- Provide outstanding, accurate customer service to patrons by answering or appropriately directing questions and concerns
- Lead tours of sales floor within the store, making product recommendations based on ongoing research of products available
- Retain thorough and comprehensive knowledge of the patient and member benefits, discounts, coupons and promotions, encouraging memberships for medical guests
- Abide by-product handling procedures, including company safety and health policies as well as regulatory agency compliance
- Maintain cleanliness and organization of store by stocking retail items and supplies, sweeping, mopping, and sanitizing
- Operate cash register, computer-based POS system, and cash drawer
- Work as part of a team to ensure sales, guest satisfaction, and that compliance goals are met by designated timelines
- All other job duties as assigned
- Associate or Bachelor’s degree in any field preferred
- Bilingual in Spanish preferred
Jushi Holdings is a cannabis company aiming to be a world-class leader by building an integrated global community focused on wellness, mindfulness, and connection. It develops and sells cannabis products with strong branding and trusted quality across growing markets. Its products come from cultivation and manufacturing processes, then are branded and distributed to consumers to support wellness and everyday use. The company differentiates itself through its emphasis on branding, quality, and an integrated platform that links cultivation, product development, and distribution across multiple regions. Its goal is to become a leading global cannabis brand and platform that connects people seeking wellness through cannabis products.
Company Size
201-500
Company Stage
IPO
Headquarters
Boca Raton, Florida
Founded
2018
Get referred to Jushi
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue reached $71.3 million, up 9.6%, with wholesale up 68%.
- Virginia posted record quarterly revenue in Q2 2026, driven by six-store same-site growth.
- Federal rescheduling delivered a $6.4 million tax benefit and should keep boosting margins.
What critics are saying
- Jushi carries a $160 million term loan at 12.5% interest, maturing in 2029.
- Virginia adult-use starts July 1, 2027, and any delay strands Manassas expansion capacity.
- Hemp THC lawsuits against DoorDash and Total Wine expose Jushi to brutal price competition and legal spend.
What makes Jushi unique
- Jushi runs 42 dispensaries across eight states, with vertically integrated cultivation in Pennsylvania and Virginia.
- Beyond Hello plus Jushi-branded products drove 58% of Q1 2026 retail revenue.
- Management relocates dispensaries, like Belle Vernon on August 20, 2026, to improve site economics.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Short-and Long-Term Disability
Flexible Spending Accounts
Paid Time Off
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 1%Jushi Holdings relocates Beyond Hello dispensary to Belle Vernon, Pennsylvania. August 20, 2026 Jushi Holdings Inc. has opened a relocated Beyond Hello medical marijuana dispensary in Belle Vernon, Pennsylvania, shifting an existing retail license from Johnstown as the multi-state cannabis operator adjusts its retail footprint in southwestern Pennsylvania. The Beyond Hello Belle Vernon dispensary, located at 1533 Broad Ave. in Westmoreland County, began serving Pennsylvania medical marijuana patients on July 31. Jushi plans to hold a grand opening celebration on August 21. The relocation moves Jushi's former Beyond Hello Johnstown operation to a retail corridor in Belle Vernon with access to Interstate 70. The surrounding area includes national retailers, grocery stores and restaurants, giving the dispensary a more commercially concentrated location serving patients and caregivers in the Mon Valley and communities across Westmoreland, Fayette and Washington counties. For Jushi, the move represents an effort to optimize an existing Pennsylvania retail asset rather than simply add another dispensary to its portfolio. The company identified Pennsylvania as one of its most important operating markets and said the Belle Vernon location is intended to improve accessibility across the region. "Pennsylvania continues to be one of Jushi's most important operating markets, and this relocation reflects our commitment to continually enhancing the access and experience we provide to patients across the Commonwealth," said Jim Cacioppo, CEO, Chairman and founder of Jushi Holdings. The Belle Vernon store carries medical marijuana products permitted under Pennsylvania's program, including flower, vaporizers, concentrates, troches, tinctures, topicals and capsules. Products are available from multiple brands operating within the state's regulated medical marijuana market. Patients can also reserve products online for in-store pickup, adding a digital ordering component to the physical retail operation. The dispensary is open Monday through Saturday from 9 a.m. to 8 p.m. and Sunday from 10 a.m. to 7 p.m. Relocating the Johnstown dispensary allows Jushi to reposition its retail presence around a different regional customer base while continuing to operate within Pennsylvania's medical marijuana framework. Location can be particularly important for dispensary operations because patient access, traffic patterns and proximity to surrounding population centers directly affect the usefulness and performance of a retail site. "By relocating our existing dispensary to Belle Vernon, we are improving convenience and accessibility for patients and caregivers throughout the region," Cacioppo said. The company's August 21 grand opening will include promotional pricing and an educational medical card sign-up event for prospective patients. The event will provide information about obtaining a Pennsylvania medical marijuana card and answer general questions about the state's medical marijuana program. Jushi is a vertically integrated cannabis operator with operations spanning multiple parts of the cannabis supply chain. The company trades on the Canadian Securities Exchange under JUSH and on the OTCQX market under JUSHF. Its strategy includes building a portfolio of branded cannabis assets through acquisitions, distressed situations and competitive licensing applications. The Beyond Hello brand serves as the company's consumer-facing dispensary operation. The Belle Vernon relocation illustrates another component of that strategy: repositioning existing retail infrastructure when management identifies an opportunity to improve market coverage and patient access. Rather than expanding its Pennsylvania store count through the move, Jushi is reallocating an existing dispensary operation to a location with interstate access and proximity to several southwestern Pennsylvania counties. The effectiveness of the relocation will depend on how well the new site extends the company's reach among qualified patients while supporting the operating economics of its broader Pennsylvania retail network.
Jushi Holdings Inc reported Q2 2026 revenue of $71.3 million, up 9.6% from $65 million in the prior year quarter. Wholesale revenue surged 68% year-over-year to a record $9.4 million, whilst retail revenue increased approximately 4% to $61.9 million. The company posted a net loss of $7.3 million, an improvement from the prior year's $12.3 million loss. Adjusted EBITDA came in at $13.3 million with an 18.7% margin, down from 21.1% in the prior year quarter. Federal rescheduling of state-licensed medical cannabis from Schedule I to Schedule III resulted in a one-time income tax benefit of approximately $6.4 million. The company ended the quarter operating 42 stores, compared to 40 stores a year earlier. Jushi faces ongoing pricing pressure and increased promotional activity impacting margins.
Jushi Holdings reported Q1 2026 revenue of $66.4 million, up 4% year-over-year, though pricing pressures persisted across markets. Wholesale revenue rose 22.2%, driven by growth in Massachusetts and Ohio. Gross profit increased to $29.9 million, representing 45% of revenue, compared to 40.4% in the prior year. Adjusted EBITDA reached $11.4 million, with margins improving to 17.2% from 15.4%. The company ended the quarter with approximately $42 million in cash. However, the net loss widened to $19.8 million from $17 million, whilst operating expenses rose to $28.3 million due to higher employee costs and legal fees. Virginia revenue declined due to reduced wholesale demand. Management highlighted potential benefits from Virginia's adult-use cannabis legislation and the closure of hemp loopholes, focusing on domestic expansion rather than international markets.
[8-K] Jushi Holdings Inc. reports material event. Filing Impact Filing Sentiment Rhea-AI filing summary. Jushi Holdings Inc. reported first quarter 2026 results with revenue of $66.4 million, up from $63.8 million a year earlier, driven by new stores and wholesale growth. Gross profit margin improved to 45.0%, but the company recorded a net loss of $19.8 million. Adjusted EBITDA rose to $11.4 million with a 17.2% margin, and operating cash flow was $8.6 million. Jushi completed a $160.0 million secured term loan refinancing, repaying prior debt and boosting cash to $42.3 million. Management highlighted benefits from federal rescheduling of state-licensed medical marijuana, expected to reduce tax burden over time. Insights. Modest top-line growth, better margins, but losses and leverage remain. Jushi Holdings Inc. posted Q1 2026 revenue of $66.4 million, up 4% year over year, with gross margin rising to 45.0%. Adjusted EBITDA increased to $11.4 million, reflecting improved grower-processor efficiency and greater contribution from Jushi-branded products. The balance sheet shows $42.3 million in cash as of March 31, 2026, but also total gross debt of $222.1 million subject to scheduled repayments. The new $160.0 million term loan due 2029 extends maturities yet locks in a 12.5% coupon, sustaining high interest expense. Federal rescheduling of state-licensed medical marijuana to Schedule III, with medical sales about 60% of 2025 revenue, should ease tax pressure by eliminating Section 280E for those operations. Actual financial benefit will depend on future profitability and any further regulatory changes disclosed in subsequent periods. 8-K event classification. 2 items: 2.02, 9.01 Key figures. Revenue: $66.4 million Gross profit margin: 45.0% Net loss: $19.8 million +5 more Key terms. Adjusted EBITDA, original issue discount, Schedule III, Section 280E, +2 more Earnings snapshot. Revenue: $66.4 million 05/12/2026 - 01:05 PM UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): (Exact name of registrant as specified in its charter) (Address of Principal Executive Offices) (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Filing exhibits & attachments. 5 documents Press releases.
Jushi Holdings Inc reported mixed fourth-quarter 2025 results, with revenue growing 4% year-over-year whilst navigating challenging market conditions. The cannabis company posted gross profit of $28.6 million, representing 41.9% of revenue, up from 38.6% in the prior year. Adjusted EBITDA reached $13.9 million with a 20.4% margin, driven by operational improvements. However, the company reported a net loss of $15.6 million, compared to a $12.5 million loss the previous year. Jushi successfully refinanced its debt, strengthening its balance sheet. The company is positioning for growth in Virginia's anticipated adult-use cannabis market, leveraging existing infrastructure. Full-year gross margins declined slightly to 43.4% from 45.9%, reflecting ongoing pricing pressure across markets. Branded sales constitute mid-60% of revenue in most markets.